IBM Research introduces MAMMAL, a multi-modal model that combines proteins, molecules, gene data achieving SOTA on 9 out 11 biological benchmarks (beating Alpha... (opens in new tab)
Modern AI (Artificial Intelligence) methods offer new opportunities in pharmacology by enabling improved modeling of disease mechanisms and drug action learned from large and heterogeneous biological datasets. A central challenge is developing models that can jointly integrate disparate biomedical modalities. We introduce MAMMAL (Molecular Aligned Multi Modal Architecture and Language), a foundation model for cross-modal learning, designed to address the challenges associated with drug discov...
Read the original article